Form D · Biotechnology
ProActa Inc
La Jolla, CA · CIK 0001297823
Offering snapshot reported Dec 23, 2011 · SEC filing
- Reported sold
- $500K Offering amount: $3M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 15, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 23, 2011 | Initial | $500,000 | No comparison | 4 | SEC filing |
| Jul 7, 2010 | Amendment | $3,000,445 | $1,900,282vs Feb 19, 2010 | 9 | SEC filing |
| Feb 19, 2010 | Initial | $1,100,163 | No comparison | 9 | SEC filing |
| Feb 1, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Debt, Other
- Exemptions
- 06
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-170629
Convertible promissory notes and the underlying shares of equity securities issuable upon conversion of notes and conversion of equity securities.
Source: Form D, filed Dec 23, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Kevin De La Torre | Executive |
| John C. Gutheil | Director, Executive |
| Dennis Henner | Director |
| David Mack | Director |
| George Morstyn | Director |
| Brigitte Smith | Director |
| John Villiger | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
4275 Executive Square, Suite 440
La Jolla, CA, 92037
La Jolla, CA, 92037